Related Experiment Video
Updated: May 18, 2026
09:29
Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy
Published on: August 17, 2021
Vagus nerve stimulation elevates seizure threshold in the kindling model
Georgia M Alexander1, James O McNamara
1Department of Neurobiology, Duke University Medical Center, Durham, NC 27710, U.S.A.
Epilepsia
|September 11, 2012
Summary
Vagus nerve stimulation (VNS) effectively elevated seizure threshold in a rat epilepsy model. Both standard and experimental VNS patterns prevented seizure threshold reduction, establishing a model for further VNS research.
Area of Science:
- Neuroscience
- Epilepsy Research
- Medical Device Technology
Background:
- Vagus nerve stimulation (VNS) offers partial seizure relief for refractory epilepsy.
- Optimal VNS patterns and antiseizure mechanisms remain unclear.
- An animal model is needed to investigate VNS efficacy and mechanisms.
Purpose of the Study:
- To determine if VNS has antiseizure effects in the rat kindling model of epilepsy.
- To establish a preclinical model for optimizing VNS therapy.
Main Methods:
- Rats were implanted with amygdala electrodes and VNS devices.
- Kindling was induced, and electrographic seizure threshold (EST) was measured.
- VNS was applied using standard or microburst patterns, with EST reassessed at 60 minutes and 1 week.
Main Results:
- Control animals showed significant EST reduction at both time points.
- VNS, using both standard and experimental patterns, prevented EST reduction in stimulated rats.
- VNS demonstrated a protective effect against seizure threshold decline.
Conclusions:
- This study validates a VNS rat epilepsy model for mechanistic and therapeutic optimization.
- Findings support VNS as a viable strategy for elevating seizure threshold.
- Further research can utilize this model to identify optimal VNS parameters.
Related Concept Videos
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:19Seizures ll: Types
Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...